Captopril mitigates splenomegaly and myelofibrosis in the Gata1 low murine model of myelofibrosis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.13710
Abstract: Allogeneic stem cell transplantation is currently the only curative therapy for primary myelofibrosis (MF), while the JAK2 inhibitor, ruxolitinib. Has been approved only for palliation. Other therapies are desperately needed to reverse life‐threatening MF. However,… read more here.
Keywords: myelofibrosis; model; collagen expression; mitigates splenomegaly ... See more keywords